Top 10 HEOR Companies Leveraging Real-World Data (RWD)

In today's rapidly evolving healthcare landscape, Health Economics and Outcomes Research (HEOR) has become a critical pillar in demonstrating the value of therapies beyond clinical trials. As payers, regulators, and healthcare systems demand stronger evidence, companies leveraging Real-World Data (RWD) are gaining a decisive edge. From claims databases to electronic health records (EHRs), RWD is reshaping how market access decisions are made.

Here are the Top 10 HEOR companies at the forefront of real-world evidence (RWE) generation and health economic modeling.

1. DelveInsight

DelveInsight stands out as a premier HEOR and life sciences consulting firm renowned for its robust real-world data capabilities. The company delivers end-to-end HEOR solutions — from burden-of-disease studies and cost-effectiveness models to systematic literature reviews and payer value dossiers. With a dedicated team of health economists, epidemiologists, and outcomes researchers, DelveInsight helps pharmaceutical and biotech clients navigate complex reimbursement landscapes globally. Their evidence-based approach integrates RWD from diverse sources including claims data, patient registries, and EHRs to generate insights that drive market access and commercialization strategies.

2. IQVIA

IQVIA is a global leader in data analytics and technology solutions for the healthcare industry. With one of the world's largest proprietary healthcare databases, IQVIA delivers sophisticated real-world evidence studies, pharmacoeconomic modeling, and outcomes research to support regulatory submissions and payer negotiations across 100+ countries.

3. Evidera (A PPD Company)

Evidera is a leading global evidence and value consulting firm specializing in systematic reviews, meta-analyses, health technology assessments (HTA), and patient-reported outcomes (PRO). Their expertise in generating RWE makes them a go-to partner for pharma companies seeking market access in the US, EU, and beyond.

4. Parexel

Parexel integrates HEOR expertise into its broader clinical and regulatory service offerings. The company supports clients with value dossier development, indirect treatment comparisons, and RWE studies designed to align with the evolving requirements of HTA bodies like NICE, HAS, and AMNOG.

5. PRECISIONheor

PRECISIONheor is a specialized HEOR consultancy offering advanced analytics, budget impact modeling, economic evaluations, and market access strategies. They are particularly recognized for their deep therapeutic area expertise and innovative use of machine learning in real-world data analysis.

6. Covance (Labcorp Drug Development)

Covance, now part of Labcorp Drug Development, provides integrated HEOR and RWE services that span the full drug development lifecycle. Their global footprint and data partnerships allow for comprehensive observational studies and economic modeling that support reimbursement submissions worldwide.

7. RTI Health Solutions

RTI Health Solutions brings decades of experience in outcomes research, patient preference studies, and health economic modeling. Part of RTI International, this nonprofit-affiliated organization is trusted by regulators and health technology agencies for rigorous, transparent evidence generation.

8. Syneos Health

Syneos Health delivers integrated HEOR consulting alongside its clinical and commercial services. Their real-world evidence capabilities include retrospective database studies, prospective observational research, and comprehensive value story development tailored to diverse payer audiences.

9. Optum (UnitedHealth Group)

Optum leverages one of the largest real-world healthcare datasets in the United States — encompassing over 200 million patient records — to deliver powerful HEOR insights. Their analytics platform supports payer decision-making, comparative effectiveness research, and population health management at scale.

10. Cytel

Cytel is a global leader in statistical software and clinical analytics with a strong HEOR division. The company specializes in network meta-analyses, adaptive trial designs, and real-world evidence solutions that bridge the gap between clinical data and health economic decision-making.

Conclusion

The demand for robust real-world evidence in healthcare decision-making is at an all-time high. Whether it's demonstrating cost-effectiveness to payers or building compelling HTA submissions, the companies listed above represent the gold standard in HEOR services. Choosing the right partner — one with deep expertise in data science, health economics, and regulatory strategy — can make all the difference in achieving market access success.

For pharmaceutical and biotech companies seeking a trusted partner, working with experienced HEOR Analysis Firms like DelveInsight can accelerate evidence generation and strengthen your value proposition in an increasingly competitive landscape.